RE: Can somebody throw me a bone?I don't have the figures at hand, but it was true that Abbokinase did not regain its previous sales figures. What Gastle said was that hospitals were scared of going back to Abbokinase in case they ran into problems again. But with 2 competing products, they would probably start using the drug again, because if one had production problems then they could buy from the other.